Search research articles
Contact Us
Filters
Showing results (71-80 of 218) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1984
5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract
J H Harvey, F P Smith, P S Schein
Biochemical Pharmacology
|
December 1, 1983
Alkylating agent interactions with the nuclear matrix
K D Tew, A L Wang, P S Schein
Seminars in Oncology
|
December 1, 1984
Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity
A Rahman, A Fumagalli, A Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy
J E Cantrell, T M Phillips, P S Schein
Endocrinology
|
September 1, 1971
Effects of streptozotocin on carbohydrate and lipid metabolism in the rat
P S Schein, K G Alberti, D H Williamson
Seminars in Oncology
|
December 1, 1975
Nutritional complications of cancer and its treatment
P S Schein, J S Macdonald, C Waters, et al.
Antibiotics and Chemotherapy
|
January 1, 1978
Pharmacology of nitrosourea antitumor agents
P S Schein, J Heal, D Green, et al.
Cancer Research
|
February 1, 1978
Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea
P S Schein, J M Bull, D Doukas, et al.
Bulletin Du Cancer
|
January 1, 1979
Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors
B Ardalan, J S Macdonald, D Cooney, et al.
Cancer Treatment Reports
|
June 1, 1976
Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent
P S Schein, L Panasci, P V Woolley, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 218) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1984
5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract
J H Harvey, F P Smith, P S Schein
Biochemical Pharmacology
|
December 1, 1983
Alkylating agent interactions with the nuclear matrix
K D Tew, A L Wang, P S Schein
Seminars in Oncology
|
December 1, 1984
Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity
A Rahman, A Fumagalli, A Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy
J E Cantrell, T M Phillips, P S Schein
Endocrinology
|
September 1, 1971
Effects of streptozotocin on carbohydrate and lipid metabolism in the rat
P S Schein, K G Alberti, D H Williamson
Seminars in Oncology
|
December 1, 1975
Nutritional complications of cancer and its treatment
P S Schein, J S Macdonald, C Waters, et al.
Antibiotics and Chemotherapy
|
January 1, 1978
Pharmacology of nitrosourea antitumor agents
P S Schein, J Heal, D Green, et al.
Cancer Research
|
February 1, 1978
Sensitivity of human and murine hematopoietic precursor cells to 2-[3-(2-chloroethyl)-3-nitrosoureido]-D-glucopyranose and 1,3-bis(2-chloroethyl)-1-nitrosourea
P S Schein, J M Bull, D Doukas, et al.
Bulletin Du Cancer
|
January 1, 1979
Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors
B Ardalan, J S Macdonald, D Cooney, et al.
Cancer Treatment Reports
|
June 1, 1976
Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent
P S Schein, L Panasci, P V Woolley, et al.
Page
of 22